"submissionclasscodeid","submissionclasscode","submissionclasscodedescription","tecode"
1,"BIOEQUIV","Bioequivalence",
2,"EFFICACY","Efficacy",
3,"LABELING","Labeling",
4,"MANUF (CMC)","Manufacturing (CMC)",
5,"N/A","Not Applicable",
6,"S","Supplement",
7,"TYPE 1","Type 1 - New Molecular Entity",
8,"TYPE 1/4","Type 1 - New Molecular Entity and Type 4 - New Combination",
9,"TYPE 2","Type 2 - New Active Ingredient",
10,"TYPE 2/3","Type 2 - New Active Ingredient and Type 3 - New Dosage Form",
11,"TYPE 2/4","Type 2 New Active Ingredient and Type 4 New Combination",
12,"TYPE 3","Type 3 - New Dosage Form",
13,"TYPE 3/4","Type 3 - New Dosage Form and Type 4 - New Combination",
14,"TYPE 4","Type 4 - New Combination",
15,"TYPE 5","Type 5 - New Formulation or New Manufacturer",
16,"TYPE 6","Type 6 - New Indication (no longer used)",
17,"TYPE 7","Type 7 - Drug Already Marketed without Approved NDA",
18,"TYPE 8","Type 8 - Partial Rx to OTC Switch",
19,"UNKNOWN",,
20,"Unspecified",,
21,"REMS","REMS",
22,"TYPE 10","Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
23,"MEDGAS","Medical Gas",
24,"TYPE 9","Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval",
25,"TYPE 9- BLA","Type 9 - New indication submitted as distinct BLA, consolidated",
